a late (postnatal) increase in ossification. To mimic GSK-3b or Axin2 loss, we are over-expressing a drug-stabilised b-catenin construct in wild-type skull osteoblast cultures, and in skull explant (calvarial) cultures. Using a drug-dependent b-catenin will allow us to investigate the threshold levels of Wnt signalling required for ossification and the stages at which the b-catenin signal is critical for osteoblast differentiation. Our findings from these investigations will be reported here. Overexpression and knockdown analysis of snoN1, snoN2, and 
However the processes in which Notch acts and which particular components are involved is not well understood. To investigate this invivo we began to analyse few known cell markers on sections of Dll1 mutant lungs and in lungs of embryos with pharmacologically inhibited Notch activation. All cell types appear to be S318
